TOKYO, June 27 (Reuters) - Japanese technology investor

SoftBank Group ( SFTBF ) has launched a joint venture with Tempus

AI ( TEM ) that aims to analyse personal medical data with

artificial intelligence (AI) to come up with treatment

recommendations.

This is the latest in a string of AI investments SoftBank

has recently announced as it increases the pace of its

investment activity after a muted few years.

SoftBank invested around $200 million in Tempus in its

series G funding round in April before Tempus listed on the

Nasdaq in June.

($1 = 160.4700 yen)